Natalia Garcia-Morales
Overview
Explore the profile of Natalia Garcia-Morales including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laserna-Mendieta E, Casabona-Frances S, Amorena E, Savarino E, Perez-Martinez I, Blas-Jhon L, et al.
United European Gastroenterol J
. 2024 Nov;
12(10):1388-1398.
PMID: 39513462
Background: Eosinophilic esophagitis (EoE) predominantly affects males across all ages; however, little is known about sex differences for other aspects of EoE. Objective: To investigate associations between sex and clinical...
2.
Fuentes-Valenzuela E, Delgado-Guillena P, Velamazan-Sandalinas R, Sanchez J, Garcia-Morales N, Barrio J, et al.
Gastroenterol Hepatol
. 2024 Sep;
47(8):901-905.
PMID: 39349042
No abstract available.
3.
Tejedor-Tejada J, Ballester M, Del Castillo-Corzo F, Garcia-Mateo S, Domper-Arnal M, Parada-Vazquez P, et al.
Eur J Gastroenterol Hepatol
. 2024 Sep;
37(1):15-23.
PMID: 39324889
Introduction: Patient blood management (PBM) adherence in clinical practice is unclear. This real-world practice study assessed the management of patients with gastrointestinal (GI) bleeding after the implementation of the PBM...
4.
Navarro P, Feo-Ortega S, Casabona-Frances S, Gutierrez-Junquera C, Savarino E, Amorena E, et al.
Eur J Pediatr
. 2024 May;
183(8):3567-3578.
PMID: 38819501
This study compared short-term effectiveness of proton pump inhibitors (PPI), swallowed topical corticosteroids (STC), and dietary therapies in reversing clinical and histological features in pediatric patients with eosinophilic esophagitits (EoE)....
5.
Mesonero F, Zabana Y, Fernandez-Clotet A, Leo-Carnerero E, Caballol B, Nunez-Ortiz A, et al.
Therap Adv Gastroenterol
. 2024 Mar;
17:17562848241234476.
PMID: 38445247
Background: The usefulness of thiopurines has been poorly explored in pouchitis and other pouch disorders. Objective: To evaluate the effectiveness and safety of azathioprine as maintenance therapy in inflammatory pouch...
6.
Bujanda L, Nyssen O, Ramos J, Bordin D, Tepes B, Perez-Aisa A, et al.
Am J Gastroenterol
. 2023 Nov;
119(4):646-654.
PMID: 37983769
Introduction: Antibiotic resistance is one of the main factors that determine the efficacy of treatments to eradicate Helicobacter pylori infection. Our aim was to evaluate the effectiveness of first-line and...
7.
Delgado-Guillena P, Velamazan-Sandalinas R, Sanchez J, Fuentes-Valenzuela E, Garcia-Morales N, Cuatrecasas M, et al.
Gastroenterol Hepatol
. 2023 Sep;
46(9):727-731.
PMID: 37708969
No abstract available.
8.
Perez-Aisa A, Nyssen O, Keco-Huerga A, Rodrigo L, Lucendo A, Gomez-Rodriguez B, et al.
Gut
. 2023 Jul;
72(11):2031-2038.
PMID: 37468228
Background: The recommended schedule for single capsule bismuth quadruple therapy (scBQT, Pylera) includes a proton pump inhibitor (PPI) two times a day and three scBQT capsules four times a day....
9.
Garcia-Morales N, Perez-Aisa A, Fiorini G, Tepes B, Castro-Fernandez M, Lucendo A, et al.
J Clin Med
. 2023 Jul;
12(13).
PMID: 37445399
Background And Aims: Several methods are available to diagnose infection. Our objective was to evaluate the tests used for both the initial diagnosis and the confirmation of eradication after treatment...
10.
Laserna-Mendieta E, Navarro P, Casabona-Frances S, Savarino E, Perez-Martinez I, Guagnozzi D, et al.
Dig Liver Dis
. 2023 May;
55(8):1165-1166.
PMID: 37230859
No abstract available.